Health care professionals' preference for a fully liquid, ready-to-use hexavalent vaccine in Spain.
Prev Med Rep
; 22: 101376, 2021 Jun.
Article
en En
| MEDLINE
| ID: mdl-33996389
DTPa HBV-IPV, diphtheria-tetanus-acellular pertussis-hepatitis B recombinant (adsorbed)-inactivated poliomyelitis-adsorbed conjugated Haemophilus influenzae type b vaccine; DTaP, diphtheria, tetanus, and acellular pertussis (whooping cough); HB, hepatitis B; HCP, healthcare professionals; HPV, human papillomavirus; Hib, Haemophilus influenzae type b; ICC/ESOMAR, International Chamber of Commerce/European Society for Opinion and Market Research; IPV, inactivated polio vaccine; Lyophilized vaccines; MM, measles, mumps; MMR, measles, mumps, rubella; Medication errors; MenACWY, meningococcal conjugate vaccine; MenC, meningococcal C vaccine; PCV, pneumococcal conjugate vaccine; Pediatric vaccination; Primary healthcare; RTU, ready-to-use; Ready-to-use vaccines; Td, tetanus, diphtheria; Vaccination; WHO, World Health Organization
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Observational_studies
/
Risk_factors_studies
Aspecto:
Patient_preference
Idioma:
En
Revista:
Prev Med Rep
Año:
2021
Tipo del documento:
Article
País de afiliación:
España
Pais de publicación:
Estados Unidos